These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 148641)

  • 1. [Biological activity of fibrinogen derivatives].
    Kopeć M
    Pol Arch Med Wewn; 1978 Jan; 59(1):1-7. PubMed ID: 148641
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological effect of fibrin/fibrinogen degradation products].
    Li SQ
    Sheng Li Ke Xue Jin Zhan; 1986 Apr; 17(2):169-72. PubMed ID: 3538403
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of fibrin monomer on spontaneous platelet aggregation].
    Levin GIa; Egorikhina MN; Taranenko IA; Momot AP
    Klin Lab Diagn; 2011 Mar; (3):39-42. PubMed ID: 21584967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ; Dray L; Ardaillou N
    Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 7. The ability of fibrinogens, FI and FII, to support ADP-induced platelet aggregation.
    Phillips HM; Mansouri A; Perry CA
    Thromb Haemost; 1983 Aug; 50(2):527-9. PubMed ID: 6636032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catabolism of fibrinogen and its derivatives.
    Sherman LA
    Thromb Haemost; 1977 Dec; 38(4):809-22. PubMed ID: 341411
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of fibrinogen derivatives in obstetrical practice].
    Makatsariia AD; Mel'nikov AP; Smolianitskiĭ AIa
    Sov Med; 1979 Jun; (6):13-7. PubMed ID: 472876
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
    Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
    Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.
    Gaffney PJ
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():10-7. PubMed ID: 6448869
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation of fibrinogen by plasmin: biological effects of the non-dialysable fibrinogen derivatives.
    Triantaphyllopoulos DC; Chandra S
    Thromb Diath Haemorrh Suppl; 1973; 56():113-26. PubMed ID: 4281938
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of morphology to the identification of fibrinogen derivatives].
    Fabre J; Delsol G; Familiades J; Tapie C; Boneu B; Bierme R
    Pathol Biol (Paris); 1974 Nov; 22 suppl():53-9. PubMed ID: 4620096
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemostatic changes in late pregnancy toxicosis].
    Kholevich B
    Akush Ginekol (Sofiia); 1984; 23(5):452-5. PubMed ID: 6393786
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
    Alkjaersig N; Davies A; Fletcher A
    Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
    Plow EF; Edgington TS
    J Immunol; 1986 Sep; 137(6):1910-5. PubMed ID: 2943807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.